CytRx - 30 Year Stock Price History | CYTR

Historical daily share price chart and data for CytRx since 1989 adjusted for splits. The latest closing stock price for CytRx as of June 03, 2019 is 0.31.
  • The all-time high CytRx stock closing price was 1868.91 on January 15, 1992.
  • The CytRx 52-week high stock price is 0.00, which is -100% above the current share price.
  • The CytRx 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average CytRx stock price for the last 52 weeks is NaN.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
CytRx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 0.6009 0.5150 0.7601 0.3100 0.3100 -30.93%
2018 1.2648 1.7500 2.2700 0.3600 0.4488 -73.44%
2017 2.8498 2.3161 5.7978 1.6900 1.6900 -24.31%
2016 9.4273 15.3569 20.9358 2.2328 2.2328 -85.95%
2015 19.4153 16.6767 31.6137 12.1776 15.8968 -3.28%
2014 23.2619 41.3917 48.4703 12.8974 16.4367 -56.30%
2013 15.3510 11.2777 37.6125 11.2178 37.6125 235.29%
2012 18.3395 11.1370 32.5735 9.7780 11.2178 -4.56%
2011 26.1511 44.0780 44.0780 10.7088 11.7541 -72.28%
2010 41.0430 45.3373 59.1904 27.7061 42.3988 -9.82%
2009 30.9073 12.5895 54.1529 10.0834 47.0165 273.33%
2008 38.5034 109.9850 109.9850 10.4948 12.5937 -89.44%
2007 152.6642 78.9205 216.1919 75.5622 119.2204 48.69%
2006 61.1262 42.8186 94.0330 39.4603 80.1799 85.44%
2005 44.0439 57.9310 73.0435 31.9040 43.2384 -26.43%
2004 62.7751 80.1799 94.4528 39.4603 58.7706 -24.73%
2003 67.9707 11.3343 132.2339 9.2354 78.0810 644.00%
2002 24.6686 27.2864 44.0780 9.2354 10.4948 -61.54%
2001 36.6581 34.1079 49.5352 21.8291 27.2864 -9.57%
2000 62.9122 44.4977 262.3688 23.5082 30.1745 -20.69%
1999 101.6528 44.6237 141.6792 34.1079 38.0456 -6.45%
1998 84.5886 141.6792 152.1739 31.4843 40.6693 -67.03%
1997 168.7556 139.0765 236.1319 123.3343 123.3343 -14.59%
1996 179.1622 199.8201 241.3793 138.9505 144.4078 -23.56%
1995 323.8014 230.8845 524.7376 152.1319 188.9055 -14.32%
1994 749.6018 1049.4752 1322.3388 215.1004 220.4737 -78.99%
1993 834.3164 902.5487 1165.0014 566.7166 1049.4752 19.05%
1992 1015.8087 1007.4962 1868.9054 587.7061 881.5592 -11.59%
1991 419.7196 136.4318 1081.0434 136.4318 997.0854 660.02%
1990 333.0342 320.0480 598.2848 131.1928 131.1928 -54.58%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.006B $0.000B
CYTRX CORP. is engaged in the development and commercialization of pharmaceutical related products and services including human therapeutics focused on high-value critical- care therapies.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.107B 9.86
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.761B 16.99
Biohaven Pharmaceutical Holding (BHVN) United States $10.111B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.648B 0.00
Emergent Biosolutions (EBS) United States $1.770B 7.57
Arcus Biosciences (RCUS) United States $1.376B 34.89
Myovant Sciences (MYOV) United Kingdom $1.033B 0.00
Zymeworks (ZYME) Canada $0.397B 0.00
Gelesis Holdings (GLS) United States $0.345B 0.00
Ambrx Biopharma (AMAM) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.110B 22.60
SQZ Biotechnologies (SQZ) United States $0.100B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00